Next Article in Journal
Non-Fasting Hypertriglyceridemia Burden as a Residual Risk of the Progression of Carotid Artery Stenosis
Next Article in Special Issue
A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy
Previous Article in Journal
Is Endophytic Colonization of Host Plants a Method of Alleviating Drought Stress? Conceptualizing the Hidden World of Endophytes
Previous Article in Special Issue
Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment
 
 
Review
Peer-Review Record

Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer

Int. J. Mol. Sci. 2022, 23(16), 9195; https://doi.org/10.3390/ijms23169195
by Wei-Chiao Chiu 1,2,†, Da-Liang Ou 3,4,† and Ching-Ting Tan 2,5,6,7,*
Reviewer 1:
Reviewer 2: Anonymous
Reviewer 3:
Int. J. Mol. Sci. 2022, 23(16), 9195; https://doi.org/10.3390/ijms23169195
Submission received: 1 July 2022 / Revised: 5 August 2022 / Accepted: 12 August 2022 / Published: 16 August 2022
(This article belongs to the Special Issue Immune Checkpoint Inhibitors and Immune Checkpoint Resistance)

Round 1

Reviewer 1 Report

This is a nice and original literature review regarding the mouse models for immune checkpoint inhibitors for oral cancer.                                                                                                               The survey of the literature is satisfactory and references are adequate.

Author Response

Thank you very much for your comments, please also refer to the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

In this manuscript, the authors reviewed the oral squamous cell carcinoma (OSCC) mouse models for immune checkpoint blockade drugs, such as immune checkpoint inhibitors (ICIs) and related treatments. First, the authors raised the point that good in vivo models, such as mouse models, are relatively low cost and can form tumors easily. Second, the authors did a comprehensive review of the existing mouse models: syngeneic tumor mouse models, chemical carcinogen-induced models, genetically engineered mouse models, and humanized mouse models. By summarizing the advantages and disadvantages of these tumor models from existing literature, this review could provide help when choosing a mouse model for related OSCC research. 

One minor thing to change is in the abstract, the order of the mouse models should be in line as in the main manuscript, not in the revered order.

Author Response

Thank you very much for your comments; please also refer to the attachment.

Author Response File: Author Response.pdf

Reviewer 3 Report

In their review "Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer" the authors  present evidence and considerations for choosing a suitable model establishment method to investigate the early diagnosis, clinical treatment, and related pathogenesis of OSCC.

The review is very interesting and provides useful information about a current need in medicine. 

I would sugguste to make the folliowng corrections/additions to improve the quality of this review.

- Figure 1: needs some stylish workup (alignement of text, placement of text in graphic, colour selection, font size ....

- Table 1: here it would be helpful to make a graphical presentation of the results of the different studies - how do they compare - or how are they comparable - statistical analysis of the studies: what were the outcomes?

After these corrections, I suggest for publication

 

Author Response

Thank you very much for your comments; please also refer to the attachment.

Author Response File: Author Response.pdf

Back to TopTop